Company BioPorto A/S

Equities

BIOPOR

DK0011048619

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Copenhagen 11:59:34 2024-03-27 am EDT 5-day change 1st Jan Change
1.308 DKK -2.10% Intraday chart for BioPorto A/S -2.53% -37.42%

Business Summary

Bioporto A/S is a Denmark-based company engaged in the development and marketing of in vitro diagnostic (IVD) assays. The Company's portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test for diagnosing acute kidney injury; NGAL Enzyme-linked immunosorbent assay (ELISA) kits, which supplies NGAL for the development of medicines for estimating side-effects that are harmful to kidneys; Mannan-binding Lectin (MBL) ELISA kit, which offers monoclonal MBL antibodies that are responsible for the activation of immune response; Antibodies, including monoclonal antibodies used in a range of research areas, such as microbiology, biomarkers, peptide hormones and plasma proteins; and Activated Protein C with Protein C Inhibitor Complex (APC-PCI), a biomarker applied to patients with sepsis and thrombotic and hemostatic disorders. In addition, the Company is a parent of BioPorto Diagnostics A/S.

Number of employees: 33

Sales per Business

DKK in Million2021Weight2022Weight Delta
Neutrophil Gelatinase-associated Lipocalin
51.3 %
12 49.9 % 15 51.3 % +22.87%
Antibodies
41.5 %
9 37.5 % 12 41.5 % +32.29%
Enzyme-linked Immunosorbent Assay Kits
6.3 %
2 10.3 % 2 6.3 % -26.41%
Royalty
0.8 %
0 0.3 % 0 0.8 % +285.71%

Sales per region

DKK in Million2021Weight2022Weight Delta
North America
51.6 %
13 55.5 % 15 51.6 % +11.17%
Europe
34.8 %
8 31.8 % 10 34.8 % +30.90%
Asia
13.5 %
3 12.6 % 4 13.5 % +27.86%
Other Countries
0.0 %
0 0.1 % 0 0.0 % -76.67%

Managers

Managers TitleAgeSince
Chief Executive Officer 64 13-07-17
Chief Tech/Sci/R&D Officer - 20-11-30
Chief Tech/Sci/R&D Officer - 22-06-30
Chief Operating Officer 63 15-10-03
Sales & Marketing - 19-04-30

Members of the board

Members of the board TitleAgeSince
Chairman 65 21-04-28
Director/Board Member 74 21-04-28
Chief Executive Officer 64 13-07-17
Director/Board Member 51 19-08-14
Chief Operating Officer 63 15-10-03

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 379,670,461 338,546,015 ( 89.17 %) 13,000 ( 0.003424 %) 89.17 %

Shareholders

NameEquities%Valuation
40,212,165 10.59 % 9 M kr
Media-Invest Danmark A/S
7.366 %
27,967,206 7.366 % 6 M kr
Danske Bank A/S (Investment Management)
0.1648 %
625,553 0.1648 % 143 483 kr
558,108 0.1470 % 128 013 kr
Mandarine Gestion SA
0.0746 %
283,326 0.0746 % 64 986 kr
209,291 0.0551 % 48 005 kr
131,882 0.0347 % 30 250 kr
Dimensional Fund Advisors Ltd.
0.0292 %
110,758 0.0292 % 25 405 kr
Sydbank A/S (Investment Management)
0.0127 %
48,076 0.0127 % 11 027 kr
BIOPORTO A/S
0.003424 %
13,000 0.003424 % 2 982 kr

Holdings

NameEquities%Valuation
13,000 0.00% 2,982 $

Company contact information

Bioporto A/S

Tuborg Havnevej 15 Ground Floor

2900, Hellerup

+45 45 29 00 00

http://www.bioporto.com
address BioPorto A/S(BIOPOR)